These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 455797)

  • 1. Effect of indomethacin on blastogenesis of lymphocytes from cancer patients: differentiation of patient types.
    Vosixa G; Thies J
    Clin Immunol Immunopathol; 1979 May; 13(1):30-8. PubMed ID: 455797
    [No Abstract]   [Full Text] [Related]  

  • 2. Indomethacin-mediated enhancement of lymphocyte response to mitogens in healthy subjects and lung cancer patients.
    Han T; Takita H
    Cancer; 1980 Dec; 46(11):2416-20. PubMed ID: 6969110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indomethacin enhancement of immunocompetence in melanoma patients.
    Tilden AB; Balch CM
    Surgery; 1981 Jul; 90(1):77-84. PubMed ID: 6972628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of indomethacin on the in vitro lymphocyte transformation response to herpes simplex virus antigen and phytohemagglutinin after marrow transplant.
    Meyers JD; Wade JC; Day LM
    J Infect Dis; 1982 Aug; 146(2):289. PubMed ID: 6286791
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro effect of indomethacin on mitogen-induced lymphoproliferative response in lung cancer patients.
    Stanojević-Bakić N; Vucković-Dekić L; Susnjar S; Spuzić I
    Neoplasma; 1992; 39(2):129-32. PubMed ID: 1326720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indomethacin augments inhibitory effects of interferons on lymphoproliferative response.
    Aoki N; Maruyama Y; Ohno Y; Azuma Y
    Immunol Lett; 1984; 7(6):321-4. PubMed ID: 6724639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of monocytes to the decreased lymphoproliferative response to phytohemagglutinin in patients with lung cancer.
    Fariñas MC; Rodriguez-Valverde V; Zarrabeitia MT; Parra-Blanco JA; Sanz-Ortiz J
    Cancer; 1991 Sep; 68(6):1279-84. PubMed ID: 1873782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of the effects of preincubation and indomethacin on lymphocyte transformation.
    Sohnle PG; Collins-Lech C
    Clin Immunol Immunopathol; 1979 May; 13(1):47-55. PubMed ID: 455798
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism of suppression of the depressed lymphocyte response in lung cancer patients.
    Alberola V; González-Molina A; Trenor A; San Martín B; Lluch A; Palau F; Marín J; García-Conde FJ
    Allergol Immunopathol (Madr); 1985; 13(3):213-9. PubMed ID: 2931010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of phytohemagglutinin-induced lymphoproliferative response by indomethacin, Thymex L or their combination in lung cancer patients.
    Stanojević-Bakić N; Vucković-Dekić L; Frim O; Rajner L; Spuzić I
    Anticancer Drugs; 1993 Oct; 4(5):565-9. PubMed ID: 8292814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combination chemotherapy on immunoregulatory cells in peripheral blood of solid tumor cancer patients: correlation with rebound overshoot immune function recovery.
    Braun DP; Harris JE
    Clin Immunol Immunopathol; 1981 Aug; 20(2):193-214. PubMed ID: 6455230
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro and in vivo effects of indomethacin on phytohemagglutinin-stimulated lymphocyte mitogenesis.
    Seng GF; Gay BJ; Bayer BM
    Biochem Pharmacol; 1987 Feb; 36(4):507-11. PubMed ID: 3827938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of aldosterone on the phytohemagglutinin-induced human lymphocyte blastogenesis.
    Wajner M; Arruda NB
    Rev Bras Biol; 1985 Nov; 45(4):557-61. PubMed ID: 3834531
    [No Abstract]   [Full Text] [Related]  

  • 14. Short-term stimulation of lymphocyte proliferation by indomethacin in vitro and in vivo.
    González-Cabello R; Perl A; Kalmár L; Gergely P
    Acta Physiol Hung; 1987; 70(1):25-30. PubMed ID: 3425329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor cells in melanoma and lung cancer: correlation with the clinical stage.
    Minassian AA; Kadagidze ZG
    Neoplasma; 1983; 30(2):153-8. PubMed ID: 6221196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indomethacin-responsive mononuclear cell dysfunction in Hodgkins disease.
    DeShazo RD
    Clin Immunol Immunopathol; 1980 Sep; 17(1):66-75. PubMed ID: 7408238
    [No Abstract]   [Full Text] [Related]  

  • 17. Rosette and blastogenesis inhibition by plasma from Hodgkin's disease and other malignancies. Positive correlation in State I and II Hodgkin's disease.
    Sinclair T; Ezdinli EZ; Boonlayangoor P; Wasser LP; Han T
    Cancer; 1983 Jan; 51(2):238-44. PubMed ID: 6336976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired proliferative response and low interleukin-2 production in patients with lymphoma.
    Musatti CC; Yasaka K; Santos LM
    Braz J Med Biol Res; 1987; 20(3-4):351-62. PubMed ID: 3502537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic monitoring during combined radiochemoimmunotherapy in inoperable lung cancer.
    Sega E; Rinaldi M; Mottolese M; Cordiali-Fei P; Apollonj MC; De Santis M; Gionfra T; Casali A; Gianciotta A; Gallo-Curcio C
    Oncology; 1980; 37(6):390-6. PubMed ID: 7432751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial reversal of the cellular immune defect in common variable immunodeficiency with indomethacin.
    Goodwin JS; Bankhurst AD; Murphy SA; Selinger DS; Messner RP; Williams RC
    J Clin Lab Immunol; 1978 Nov; 1(3):197-9. PubMed ID: 756469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.